Beebe Healthcare has become the first hospital in Delaware to offer the AVEIR® DR Dual Chamber Leadless Pacemaker, a newly ...

A 67-year-old man with acute anterolateral myocardial infarction had recurrent ventricular fibrillation that required insertion of temporary pacemaker. When a permanent pacemaker was inserted stable ...

Minimizing atrial pacing does not prevent atrial fibrillation in patients with sinus node dysfunction, according to late-breaking research presented in a Hot Line session today at ESC Congress 2023.

Boston, MA - Atrial overdrive pacing significantly reduces episodes of central or obstructive sleep apnea in patients previously fitted with a pacemaker for sick sinus or bradycardia-tachycardia ...

Please provide your email address to receive an email when new articles are posted on . Rate-modulated pacing at 60 bpm did not reduce AF incidence vs. nonadaptive pacing at 40 bpm in patients with ...

Minimizing atrial pacing does not alter the risk of atrial fibrillation (AF) associated with sinus node dysfunction (SND), suggest results of a trial that randomly assigned patients with SND who had ...

Amsterdam, Netherlands – 28 Aug 2023: Minimising atrial pacing does not prevent atrial fibrillation in patients with sinus node dysfunction, according to late breaking research presented in a Hot Line ...

AMSTERDAM -- Reducing atrial pacing didn't help prevent atrial fibrillation (Afib, or AF) in patients with sinus node dysfunction but did increase risk of fainting, the DANPACE II trial showed. The ...

The Aveir DR dual-chamber leadless pacemaker system (Abbott) performs well out to 1 year in patients largely treated for sinus node dysfunction or atrioventricular (AV) block, according to extended ...

NEW ORLEANS, LA—Rate-adaptive atrial pacing to increase heart rate during exercise is not a useful strategy in patients who have heart failure with preserved ejection fraction (HFpEF) and chronotropic ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window NEW ORLEANS -- A ...

Last week, Abbott began the commercial launch of its new leadless pacemaker, which it believes is a historic development in the world of cardiac rhythm devices. Aveir DR is a better option than ...